Scarica l'app Stockscreener
3.24
2.70%
-0.09
Dopo l'orario di chiusura:
3.24
Precedente Chiudi:
$3.33
Aprire:
$3.33
Volume 24 ore:
548.59K
Relative Volume:
0.67
Capitalizzazione di mercato:
$268.42M
Reddito:
$70.14M
Utile/perdita netta:
$-76.24M
Rapporto P/E:
-2.9189
EPS:
-1.11
Flusso di cassa netto:
$-57.06M
1 W Prestazione:
+12.50%
1M Prestazione:
+29.60%
6M Prestazione:
-34.01%
1 anno Prestazione:
-8.99%
Intervallo 1D:
$3.23
$3.335
Intervallo di 1 settimana:
$2.81
$3.38
Portata 52W:
$1.90
$6.08
Codexis Inc Stock (CDXS) Company Profile
Nome
Codexis Inc
Settore
Industria
Telefono
650-421-8100
Indirizzo
200 PENOBSCOT DRIVE, REDWOOD CITY, CA
Confronta CDXS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CDXS
Codexis Inc
|
3.24 | 252.68M | 70.14M | -76.24M | -57.06M | -1.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Codexis Inc Stock (CDXS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-19 | Downgrade | The Benchmark Company | Buy → Hold |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-05-30 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-02-29 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2023-11-07 | Downgrade | The Benchmark Company | Buy → Hold |
| 2023-08-07 | Downgrade | TD Cowen | Outperform → Market Perform |
| 2023-05-09 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2022-03-31 | Ripresa | Piper Sandler | Overweight |
| 2022-03-02 | Ripresa | Cowen | Outperform |
| 2021-04-12 | Iniziato | Piper Sandler | Overweight |
| 2021-03-01 | Iniziato | Stifel | Buy |
| 2021-02-26 | Reiterato | H.C. Wainwright | Buy |
| 2020-03-10 | Iniziato | The Benchmark Company | Buy |
| 2019-01-17 | Aggiornamento | First Analysis Sec | Neutral → Outperform |
| 2018-05-16 | Iniziato | Stephens | Overweight |
| 2017-10-13 | Reiterato | H.C. Wainwright | Buy |
| 2017-05-31 | Iniziato | Jefferies | Buy |
| 2017-01-26 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
| 2017-01-04 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2016-01-06 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Codexis Inc Borsa (CDXS) Ultime notizie
What analysts say about Codexis Inc. stockRapid growth opportunities - Autocar Professional
Is Codexis Inc. a good long term investmentFree Popular Stock Recommendations - PrintWeekIndia
How Codexis Inc. stock compares to its top competitorsIs CNFRZ stock undervalued or overvalued nowSignificant capital appreciation - jammulinksnews.com
Codexis Inc. Stock Analysis and ForecastRobust investment performance - Autocar Professional
Major Shareholder Makes Bold Move with Codexis Stock Purchase - TipRanks
Enzymatic Solutions Leader Codexis Reveals Growth Strategy at Jefferies Healthcare Conference - Stock Titan
What drives Codexis Inc. stock priceExceptional gains - Autocar Professional
What makes Codexis Inc. stock price move sharplyFree Consultation - Newser
How Codexis Inc. stock performs during market volatilityFree Market Analysis Group - Newser
Why Codexis Inc. stock attracts strong analyst attentionTop Performing Stocks - Newser
Biocatalysis And Biocatalyst Market Set for Strong Growth Outlook: Codexis, Amano Enzyme, Biocatalysts - newstrail.com
Codexis, Inc.'s (NASDAQ:CDXS) P/S Is Still On The Mark Following 27% Share Price Bounce - 富途牛牛
What You Can Learn From Codexis, Inc.'s (NASDAQ:CDXS) P/S - simplywall.st
With 59% ownership, Codexis, Inc. (NASDAQ:CDXS) boasts of strong institutional backing - Yahoo.co
Analysts Offer Insights on Healthcare Companies: Dexcom (DXCM), Perspective Therapeutics (CATX) and Codexis (CDXS) - The Globe and Mail
Synthetic Biology Market Key Players AnalysisBota - openPR.com
Codexis, Inc. (NASDAQ:CDXS) Position Increased by Assenagon Asset Management S.A. - Defense World
Opaleye Management Makes a Bold Move with Codexis Stock Purchase! - TipRanks
Millennium Management LLC Has $171,000 Position in Codexis, Inc. (NASDAQ:CDXS) - Defense World
Bank of America Corp DE Has $364,000 Holdings in Codexis, Inc. (NASDAQ:CDXS) - Defense World
Cantor Fitzgerald Forecasts Codexis FY2026 Earnings - Defense World
Squarepoint Ops LLC Has $253,000 Position in Codexis, Inc. (NASDAQ:CDXS) - Defense World
Investor Network: Codexis, Inc. to Host Earnings Call - ACCESS Newswire
Two Sigma Investments LP Buys 6,397 Shares of Codexis, Inc. (NASDAQ:CDXS) - Defense World
Codexis Inc Azioni (CDXS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.32%
1.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):